[1] Deng G. Integrative medicine therapies for pain management in cancer patients[J]. Cancer J, 2019,25:343-348. [2] Schaefer CP, Tome ME, Davis TP. The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse[J]. Fluids Barriers CNS, 2017,14:32. doi:10.1186/s12987-017-0080-3. [3] Bai X, Huang Y, Zhang K, et al. CircNf1-mediated CXCL12 expression in the spinal cord contributes to morphine anal-gesic tolerance[J]. Brain Behav Immun, 2023,107:140-151. [4] Chen X, Geller EB, Rogers TJ, et al. Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats[J]. Drug Alcohol Depend, 2007,88: 36-41. [5] Zhang TJ, Qiu Y, Hua Z. The emerging perspective of morphine tolerance: microRNAs[J]. Pain Res Manag, 2019,2019:9432965. doi:10.1155/2019/9432965. [6] Guo XY, Liu QL, Liu W, et al. Effect and mechanism of miR-135a-5p/CXCL12/JAK-STAT axis on inflammatory response after myocardial infarction[J]. Eur Rev Med Pharmacol Sci, 2020,24: 12912-12928. [7] Wan L, Jia RM, Ji LL, et al. AMPK-autophagy-mediated inhibition of microRNA-30a-5p alleviates morphine tolerance via SOCS3-dependent neuroinflammation suppression[J]. J Neuroinflammation, 2022,19: 25. doi:10.1186/s12974-022-02384-3. [8] 唐淑洁, 张佳琦, 刘洋, 等. 洛芬待因与吗啡交替服用减少吗啡在癌痛患者中的耐药性[J]. 中国医学创新, 2016,6: 29-31. [9] Paul AK, Smith CM, Rahmatullah M, et al. Opioid analgesia and opioid-induced adverse effects: a review[J]. Pharmaceuticals (Basel), 2021,14:1091. doi:10.3390/ph14111091. [10] Hill R, Canals M. Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology[J]. Pharmacol Ther, 2022,230:107961. doi:10.1016/j.pharmthera.2021.107961. [11] Zhou J, Ma R, Jin Y, et al. Molecular mechanisms of opioid tolerance: from opioid receptors to inflammatory mediators (Review)[J]. Exp Ther Med, 2021,22:1004. doi:10.3892/etm.2021.10437. [12] Choi E, Lee H, Park HS, et al. Effect of intraoperative infusion of ketamine on remifentanil-induced hyperalgesia[J]. Korean J Anesthesiol, 2015, 68: 476-480. [13] Matsushita Y, Ueda H. Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation[J]. Neuroreport, 2009,20: 63-68. [14] Inan S, Chen X, Eisenstein EM, et al. Chemokine receptor antagonists enhance morphine′s antinociceptive effect but not respiratory depression[J]. Life Sci, 2021,285: 120014. doi:10.1016/j.lfs.2021.120014. [15] Liu M, Cheng X, Yan H, et al. miR-135-5p alleviates bone cancer pain by regulating astrocyte-mediated neuroinflammation in spinal cord through JAK2/STAT3 signaling pathway[J]. Mol Neurobiol, 2021,58: 4802-4815. |